Home > Drug Search >
  • company_query: Aclaris Therapeutics
  •   > 
Drug Filter
Category:
chemistry (17) biology (14)
Status:
NDA Filing (1) BLA Filing (1) Phase Ⅲ (4) Phase Ⅱ (17) Phase Ⅰ (8)
Clinical Stage:
Pending (4) Active (19) Discontinued (8)
Bio-Type:
Vaccine (10) Whole antibody (3)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (2) Atherosclerosis (1) Benign prostatic hypertrophy (1) Breast cancer (1) Endometrial cancer (1) Common warts (1) Urogenital cancer (2) Hepatocellular carcinoma (HCC) (1) Hyperlipidemia (1) Medulloblastoma (1) Migraine (1) Multiple myeloma (MM) (2) Myelodysplastic syndrome (MDS) (1) Non small cell lung cancer (NSCLC) (2) Obesity (1) Ovarian cancer (2) Pancreatic cancer (1) Postmenopausal osteoporosis (1) Solid tumours (3) Type 2 diabetes (1) Visceral leishmaniasis (1) Head and neck cancer (1) Colorectal cancer (1) Fungal infection (1) Age-related macular degeneration (AMD) (2) Sickle cell disease (1) Contraception (1) Glioblastoma (1) Mesothelioma (1) Thelassemia (1) Seborrheic keratosis (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top